DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,911,362 | +8.2% | 7,704 | +4.7% | 0.25% | +13.0% |
| Q2 2023 | $1,766,400 | -4.5% | 7,360 | +0.3% | 0.22% | -11.5% |
| Q1 2023 | $1,849,470 | +94020.6% | 7,338 | -0.9% | 0.25% | -13.7% |
| Q4 2022 | $1,965 | -99.9% | 7,405 | -0.1% | 0.29% | -6.1% |
| Q3 2022 | $1,914,000 | -6.2% | 7,410 | -7.9% | 0.31% | -1.9% |
| Q2 2022 | $2,040,000 | -60.8% | 8,047 | -54.6% | 0.32% | -61.0% |
| Q1 2022 | $5,202,000 | -14.4% | 17,733 | -4.0% | 0.81% | -3.2% |
| Q4 2021 | $6,075,000 | +7.4% | 18,464 | -0.6% | 0.84% | +1.9% |
| Q3 2021 | $5,654,000 | +10.0% | 18,573 | -3.0% | 0.82% | +5.6% |
| Q2 2021 | $5,139,000 | +18.9% | 19,149 | -0.3% | 0.78% | +11.0% |
| Q1 2021 | $4,321,000 | -4.4% | 19,198 | -5.7% | 0.70% | -7.9% |
| Q4 2020 | $4,522,000 | +3.1% | 20,360 | 0.0% | 0.76% | -9.9% |
| Q3 2020 | $4,384,000 | +20.3% | 20,360 | +0.4% | 0.85% | +10.7% |
| Q2 2020 | $3,643,000 | +32.3% | 20,279 | +1.9% | 0.76% | +7.3% |
| Q1 2020 | $2,753,000 | -1.5% | 19,893 | +9.3% | 0.71% | +37.5% |
| Q4 2019 | $2,794,000 | -1.6% | 18,205 | -7.4% | 0.52% | -7.5% |
| Q3 2019 | $2,840,000 | +1.7% | 19,665 | +0.7% | 0.56% | -0.5% |
| Q2 2019 | $2,792,000 | +7.8% | 19,538 | -0.4% | 0.56% | +4.5% |
| Q1 2019 | $2,590,000 | +27.6% | 19,622 | -0.3% | 0.54% | +11.8% |
| Q4 2018 | $2,029,000 | +0.2% | 19,680 | +5.6% | 0.48% | +16.7% |
| Q3 2018 | $2,024,000 | +11.8% | 18,633 | +1.5% | 0.41% | +5.1% |
| Q2 2018 | $1,811,000 | +1.3% | 18,359 | +0.5% | 0.39% | +0.5% |
| Q1 2018 | $1,787,000 | +4.7% | 18,261 | -0.7% | 0.39% | +8.3% |
| Q4 2017 | $1,706,000 | +11.1% | 18,385 | +2.7% | 0.36% | +8.1% |
| Q3 2017 | $1,535,000 | -3.8% | 17,906 | -5.3% | 0.33% | -4.0% |
| Q2 2017 | $1,596,000 | -2.2% | 18,917 | -0.9% | 0.35% | -7.7% |
| Q1 2017 | $1,632,000 | +10.2% | 19,081 | +0.3% | 0.38% | +6.2% |
| Q4 2016 | $1,481,000 | -0.8% | 19,032 | -0.1% | 0.36% | -2.5% |
| Q3 2016 | $1,493,000 | -48.6% | 19,058 | -33.7% | 0.36% | -51.8% |
| Q2 2016 | $2,903,000 | +6.5% | 28,751 | -0.0% | 0.76% | +2.2% |
| Q1 2016 | $2,727,000 | +2.2% | 28,759 | +0.1% | 0.74% | -2.8% |
| Q4 2015 | $2,669,000 | +8.2% | 28,744 | -0.7% | 0.76% | +2.8% |
| Q3 2015 | $2,466,000 | -1.2% | 28,951 | -0.8% | 0.74% | +3.2% |
| Q2 2015 | $2,497,000 | -3.6% | 29,189 | -4.4% | 0.72% | -3.5% |
| Q1 2015 | $2,591,000 | +53.8% | 30,525 | +55.1% | 0.74% | +39.0% |
| Q4 2014 | $1,685,000 | +80.0% | 19,677 | +59.7% | 0.53% | +67.9% |
| Q3 2014 | $936,000 | -6.0% | 12,318 | -2.6% | 0.32% | -1.9% |
| Q2 2014 | $996,000 | +6.0% | 12,653 | +0.9% | 0.32% | -8.5% |
| Q1 2014 | $940,000 | -4.6% | 12,534 | -1.8% | 0.35% | -10.6% |
| Q4 2013 | $985,000 | +10.5% | 12,763 | -0.7% | 0.40% | -1.7% |
| Q3 2013 | $891,000 | +6.3% | 12,859 | -2.9% | 0.40% | +4.7% |
| Q2 2013 | $838,000 | 0.0% | 13,245 | 0.0% | 0.38% | 0.0% |
| Q1 2013 | $838,000 | – | 13,245 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |